Fatty Liver Disease Subtypes: Mayo Finds Five Types

Scientists say fatty liver disease subtypes are real, and there are five of them. Researchers at Mayo Clinic and Virginia Tech report that a condition affecting nearly thirty percent of adults worldwide is not one disease at all, according to ScienceDaily. The finding could change how doctors screen and treat it.

The work was published in Nature Communications. It looks at metabolic dysfunction-associated steatotic liver disease, known as MASLD, which used to be called nonalcoholic fatty liver disease. Here is what the team found and why it matters.

One Diagnosis, Five Different Stories

Until now, a patient told they have fatty liver got the same label no matter how their body got there. The new study suggests that label hides several biological pathways. Some are tied closely to obesity and diabetes, while others look driven by inherited genetic differences.

That matters because the five fatty liver disease subtypes carry different risks. The groups differ in their odds of liver failure, cancer, heart disease and even the need for a liver transplant, according to the Mayo Clinic newsroom. Two people with the same scan result could be heading in very different directions.

How Researchers Found Them

The team combined genetic sequencing results with detailed medical records from more than four thousand six hundred patients diagnosed with MASLD. They looked at liver enzymes, body mass index, blood fats and other markers of metabolic health. They also factored in conditions like diabetes, depression and sleep apnea.

Computer models then hunted for patterns linking patients with similar genetics and clinical profiles. Five distinct groups popped out. The data came from Mayo Clinic's Research Data Atlas, which links DNA information to health records, and from the Tapestry Study, which holds exome data from more than one hundred thousand participants.

"When clinical and genomic data are analyzed together at this scale, you begin to see patterns of disease progression that would otherwise remain hidden," said Shulan Tian, a bioinformatician at Mayo Clinic and co-senior author.

The Genetic Forms Are the Scary Ones

The biggest takeaway involves the inherited subtypes. People in those groups were more likely to progress to advanced liver damage, even when they lacked the usual metabolic risk factors. In other words, a person who looks healthy on paper could still be at risk.

That challenges a common assumption that fatty liver is mostly a lifestyle problem. Lifestyle clearly plays a role in some subtypes, but the research suggests genes can push the disease along on their own. Many people have no symptoms for years, so the condition can quietly advance before anyone notices.

Links to Depression, Sleep Apnea and Migraine

For the first time, researchers tied particular fatty liver disease subtypes to depression, sleep apnea and migraine. The study does not claim the liver condition causes these problems. It does hint that shared biology could connect the liver to other body systems.

That is a reminder that organs do not work in isolation. A liver that is struggling might show up in your sleep, your mood or your head, and future research will need to untangle which way the connections run.

What Could Change for Patients

If the findings hold up, doctors may eventually sort patients by subtype. That could mean earlier screening for people with genetic forms and treatments matched to the biology driving each case. Eric Klee, a co-senior author, said the approach helps map complex disease precisely enough to "anticipate its course and intervene before the most serious damage occurs."

The team plans to test the results in larger and more diverse groups. They also want to know whether the subtypes respond differently to GLP-1 drugs, the class of medications used for type 2 diabetes and weight loss, as noted by Technology Networks.

For now, nothing changes at the doctor's office tomorrow. This is early, one study, and patients were placed in a single subtype each. Still, it points toward a future where a fatty liver diagnosis comes with a much more specific map. If you want more on this beat, browse the health section for related stories. Anyone worried about their liver should talk to a doctor rather than guess.